knowledge -WSS

knowledge

author：entertainment 2025-09-28 21:04:18 - browse：4

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Novo pauses ads for weight loss drug Wegovy amid demand

focus

explore

WSS

Young boy dies in trial for Pfizer Duchenne gene therapy

Drug companies' payments and gifts affect physicians' prescribing

Four alarming medical procedures we’re glad history forgot

Four alarming medical procedures we’re glad history forgot

How to fix the rural physician shortage in the U.S.

Millions may soon lose Medicaid when they don't have to

focus

knowledge

knowledge

Psychedelics group wrestles with new pharma identity

Study: Black kids more likely to die after surgery than white kids

Cancer drug shortages should be causing more outrage

Drug companies' payments and gifts affect physicians' prescribing

How to save PrEP access — and even expand it

Bispecific antibodies are next new thing in cancer immunotherapy

In age of alternative facts, a scholarly course on calling out crap

Reanimated hearts work just as well for transplants, study finds

What does generative AI mean for health care? We asked experts

Senate panel passes drug pricing bills, but drops one PBM reform

explore

Study: Black kids more likely to die after surgery than white kids

Insurer loopholes limit power of law against surprise medical bills

Bispecific antibodies are next new thing in cancer immunotherapy

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

The thinking behind the controversial eating disorder chatbot Tessa

Millions may soon lose Medicaid when they don't have to

focus

explore

knowledge

knowledge